NADIA ETIENNE: Open Payments
NPI 1619408341 · ZEPHYRHILLS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$255 in 14 payments from 8 companies in 2025. Trend: 2023 $334 · 2024 $464 · 2025 $255
Food & beverage: $255
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 3 | $50 |
| GlaxoSmithKline, LLC. | 2 | $46 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $38 |
| Lilly USA, LLC | 2 | $36 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| Novo Nordisk Inc | 1 | $20 |
| PFIZER INC. | 1 | $15 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
Products named: JARDIANCE, MOUNJARO, OTEZLA, TRELEGY ELLIPTA, EVENITY, Ozempic, SHINGRIX, FARXIGA.
Industry payments across FL — which companies pay providers there.
